Niagen Bioscience (NAGE) Interest & Investment Income (2010 - 2026)
Niagen Bioscience (NAGE) reported Interest & Investment Income of $375000.0 for Q1 2026, down 18.3% year-over-year from $459000.0 in Q1 2025, and down 32.07% quarter-over-quarter from $552000.0 in Q4 2025.
Niagen Bioscience (NAGE) Interest & Investment Income (2010 - 2026) Analysis & Trends
Niagen Bioscience (NAGE) has 12 years of Interest & Investment Income data on file, last reported at $375000.0 in Q1 2026.
- Interest & Investment Income for Q1 2026 came in at $375000.0, down 18.3% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.0 million (up 51.45% YoY), and the FY2025 annual result was $2.1 million, up 88.4% from the prior year.
- Interest & Investment Income declined to $375000.0 in Q1 2026 per NAGE's latest filing, from $552000.0 in the prior quarter.
- Over five years, Interest & Investment Income peaked at $564000.0 in Q3 2025 and troughed at $125000.0 in Q2 2023.
- A 4-year average of $352166.7 and a median of $327500.0 in 2023 frame the typical range for Interest & Investment Income.
- The sharpest annual moves came in 2025 and 2026: Interest & Investment Income surged 129.05% in 2025, then retreated 18.3% in 2026.
- A 4-year view of Interest & Investment Income shows it stood at $282000.0 in 2023, then soared by 32.27% to $373000.0 in 2024, then jumped by 47.99% to $552000.0 in 2025, then sank by 32.07% to $375000.0 in 2026.
- Business Quant data shows NAGE's Interest & Investment Income at $375000.0 in Q1 2026, $552000.0 in Q4 2025, and $564000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 597,319.59 |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | 305,000.00 |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -14.79 Mn |
| 10 | Niagen Bioscience | 277.31 Mn | 210.76 Mn | 19.98 Mn | 375,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 375,000.00 |
| Dec 31, 2025 | 552,000.00 |
| Sep 30, 2025 | 564,000.00 |
| Jun 30, 2025 | 552,000.00 |
| Mar 31, 2025 | 459,000.00 |
| Dec 31, 2024 | 373,000.00 |
| Sep 30, 2024 | 276,000.00 |
| Jun 30, 2024 | 241,000.00 |
| Mar 31, 2024 | 239,000.00 |
| Dec 31, 2023 | 282,000.00 |
| Sep 30, 2023 | 188,000.00 |
| Jun 30, 2023 | 125,000.00 |
| Apr 1, 2017 | 2.00 |
| Dec 31, 2016 | -92.00 |
| Oct 1, 2016 | 565.00 |
| Apr 2, 2016 | 794.00 |
| Oct 3, 2015 | 976.00 |
| Jul 4, 2015 | 645.00 |
| Jan 3, 2015 | 838.00 |
| Sep 27, 2014 | 230.00 |